Background: Primary aldosteronism is a nonsuppressible renin-independent aldosterone
production that causes hypertension and cardiovascular disease. Objective: To characterize …

… Patients in the CREDENCE trial were enrolled with an eGFR as low as 30 ml/min/1.73 m
2 and continued to be treated with canagliflozin even if their eGFR was below that threshold …

The American College of Cardiology (ACC) develops a wide range of policy documents to
provide members with guidance on clinical topics. Although Clinical Practice Guidelines …

Background: Primary aldosteronism is recognized as a severe form of renin-independent
aldosteronism that results in excessive mineralocorticoid receptor (MR) activation. Objective: …

We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the
past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely …

There is increasing evidence of a clinically relevant interplay between the renin–angiotensin–aldosterone
system and calcium-regulatory systems. Classically, the former is considered …

Observational studies in primary hyperaldosteronism suggest a positive relationship between
aldosterone and parathyroid hormone (PTH); however, interventions to better characterize …

Aims Hypertension is a well-established heart failure (HF) risk factor, especially in the context
of adverse left ventricular (LV) remodelling. We aimed to use myocardial flow reserve (MFR…

Primary aldosteronism (PA) is an endocrinopathy characterized by dysregulated aldosterone
production that occurs despite suppression of renin and angiotensin II, and that is non-…

Background: Aldosterone production and mineralocorticoid receptor activation are implicated
in myocardial fibrosis and cardiovascular events. Methods: Cardiac structure and function …